• Corpus ID: 167437614

Counterfeit Goods and the Public's Health and Safety

  title={Counterfeit Goods and the Public's Health and Safety},
  author={Michele Forzley},
Counterfeiting is a recognized problem for the intellectual property legal system and its economic and financial consequences are well documented. Media and industry reports and anecdotal stories often assert that there are public health and safety consequences to counterfeiting but no quantitative or qualitative measures in support are presented nor have studies been conducted. This is the first study to systematically review available materials in an effort to define the problem and begin the… 

Tables from this paper

The Other Global Drugs Crisis: Assessing the Scope, Impacts and Drivers of the Trade in Dangerous Counterfeit Pharmaceuticals
This paper deals with a topic heretofore largely neglected in studies of health and social policy, namely the challenge presented by the growing global trade in dangerous counterfeit medicines.
Occupational Pharmaceutical Counterfeiting Schemes: A Crime Scripts Analysis
ABSTRACT This article presents a crime script for pharmaceutical counterfeiting schemes perpetrated by licensed health care professionals; we term these types of schemes occupational pharmaceutical
Counterfeit medicines and criminal organisations
The combat against counterfeiting started during the 1980s and, at that time, was limited to sectors where it was frequently the consumer who asked for the product, and was even party to the
U.S. Intellectual Property and Counterfeit Goods—Landscape Review of Existing/Emerging Research
This report provides an overview of the international market for counterfeit goods. Specifically, the report details the overall magnitude of international counterfeit trade, and explains how
Values in motion: anti-counterfeiting measures and the securitization of pharmaceutical flows
ABSTRACT The past decade has seen an increase in anti-counterfeiting practices, especially in the pharmaceutical field. These practices aim at reducing the number of bad medicines available on the
Counterfeit luxury fashion goods have rarely been the subject of scientific studies. Very little is known about the mechanisms of this illicit market, despite the apparent prevalence and their
The relationship between risk control imperative and perceived causation: the case of product counterfeiting in China
The counterfeiting of safety critical products such as pharmaceuticals is a significant risk to public safety, but the literature suggests that much of the causation of counterfeiting is endogenous:
A DEADLY FAITH IN FAKES: Trademark Theft and the Global Trade in Counterfeit Automotive Components
Intellectual property (IP) crime remains as yet a marginal topic in sociological and criminological investigation. This neglect is due in part to the perception that such offences are ‘non-serious’
Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example
It was shown that the health impairment risk due to counterfeit PDE5Is is underestimated in the market in Japan, and Physicians should warn their patients not to buy counterfeit Pde5Is, and when they write a prescription for purchasing genuine PDE 5Is, should inform their patients of the severe health problems that occurred in Singapore.
Organised crime and the efforts to combat it: a concern for public health
It is argued that conventional approaches to tackling organised crime often have deleterious consequences for public health, and calls for an evidence-based approach with a focus on outcomes rather than ideology.


From public health to international law: possible protocols for inclusion in the Framework Convention on Tobacco Control.
  • L. Joossens
  • Medicine
    Bulletin of the World Health Organization
  • 2000
The key international areas that should be considered in tobacco control are: prices, smuggling; tax-free tobacco products; advertising and sponsorship; the Internet; testing methods; package design and labelling; agriculture; and information sharing.
The Declaration enshrines the principle WHO has publicly advocated and advanced over the last four years, namely the reaffirmation of the right of WTO Members to make full use of the safeguard provisions of the TRIPS Agreement to protect public health and enhance access to medicines.
Macroeconomics and health: investing in health for economic development
" …let me say that I hope we keep our voice clear and strong on the central task of raising the health of the poor. I can be 'realistic' and 'cynical' with the best of them—giving all the reasons why
The societal conundrum of intellectual property rights: A game‐theoretical approach to the equitable management and protection of IPR
Observes that variances in standards for and interpretations of intellectual property rights (IPR) around the globe remain one of the great challenges for marketers and stakeholders of the marketing
Diethylene glycol deaths in Haiti.
  • S. Junod
  • Political Science, Medicine
    Public health reports
  • 2000
Haiti is considered the poorest in the Western Hemisphere, and only 50% of the Haitian population has access to primary health care services, according to 1997 WHO figures.
Advances in the epidemiology of injuries as a basis for public policy.
The etiology of injuries suggests that the term injury should probably be defined so as to encompass those kinds of damage to the body that are produced by energy exchanges and that are manifested within 48 hours, or usually within considerably shorter periods.
Health policy-makers' perceptions of their use of evidence: a systematic review
Interview studies with health policy-makers provide only limited support for commonly held beliefs about facilitators of, and barriers to, their use of evidence, and raise questions about commonsense proposals for improving the use of research for policy decisions.
Reducing the burden of injury : advancing prevention and treatment
The Injury Field: Magnitude and Cost, Surveillance and Data, and Case studies on Prevention Research: Case Studies on Prevention and Trauma Care.
India agrees to help Nigeria tackle the import of fake drugs
  • A. Raufu
  • Economics
    BMJ : British Medical Journal
  • 2003
Nigeria's threat to ban the import of all drugs from countries that export fake drugs to its shores is concerned about India, one of the largest exporters of fake and substandard drugs to Nigeria.